{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:24:18Z","timestamp":1787628258714,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jmb.2005.08.037","type":"journal-article","created":{"date-parts":[[2005,9,3]],"date-time":"2005-09-03T07:14:19Z","timestamp":1125731659000},"page":"104-115","source":"Crossref","is-referenced-by-count":25,"title":["Crystal Structures of a High-affinity Macrocyclic Peptide Mimetic in Complex with the Grb2 SH2 Domain"],"prefix":"10.1016","volume":"353","author":[{"given":"Jason","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Dan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Terrence R.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2005.08.037_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00039-9","article-title":"Smart drugs: tyrosine kinase inhibitors in cancer therapy","volume":"1","author":"Shawver","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmb.2005.08.037_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/B:DRUG.0000047103.64335.b0","article-title":"Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor","volume":"23","author":"Marshall","year":"2005","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.jmb.2005.08.037_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0014-5793(01)03292-6","article-title":"Interaction domains: from simple binding events to complex cellular behavior","volume":"513","author":"Pawson","year":"2002","journal-title":"FEBS Letters"},{"key":"10.1016\/j.jmb.2005.08.037_bib4","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1128\/MCB.21.5.1540-1551.2001","article-title":"Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer","volume":"21","author":"Dankort","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jmb.2005.08.037_bib5","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1038\/sj.onc.1203859","article-title":"Met receptor tyrosine kinase: enhanced signaling through adapter proteins","volume":"19","author":"Furge","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.jmb.2005.08.037_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/1389557023405765","article-title":"SRC homology-2 inhibitors: peptidomimetic and nonpeptide","volume":"2","author":"Sawyer","year":"2002","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2174\/0929867003374390","article-title":"Recent advances in the design and synthesis of SH2 inhibitors of Src Grb2 and ZAP-70","volume":"7","author":"Vu","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib8","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2174\/1381612003398546","article-title":"Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathways","volume":"6","author":"Fretz","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jmb.2005.08.037_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/jmbi.1999.2792","article-title":"Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide","volume":"289","author":"Ogura","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2005.08.037_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1006\/jmbi.2000.4396","article-title":"Solution structure of Grb2 reveals extensive flexibility necessary for target recognition","volume":"306","author":"Yuzawa","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2005.08.037_bib11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nsb0796-586","article-title":"Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding mode","volume":"3","author":"Rahuel","year":"1996","journal-title":"Nature Struct. Biol."},{"key":"10.1016\/j.jmb.2005.08.037_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1006\/jmbi.1998.1790","article-title":"Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands","volume":"279","author":"Rahuel","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2005.08.037_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/oxfordjournals.jbchem.a022398","article-title":"Solution structure of the SH2 domain of Grb2\/Ash complexed with EGF receptor-derived phosphotyrosine containing peptide","volume":"125","author":"Tsuchiya","year":"1999","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.jmb.2005.08.037_bib14","doi-asserted-by":"crossref","first-page":"13376","DOI":"10.1021\/bi0012336","article-title":"Dimer formation through domain swapping in the crystal structure of the Grb2-SH2-Ac-pYVNV complex","volume":"39","author":"Schiering","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2005.08.037_bib15","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1006\/jmbi.2001.5299","article-title":"Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor","volume":"315","author":"Nioche","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2005.08.037_bib16","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1021\/jm030510e","article-title":"Macrocyclization in the design of non-phosphorus-containing Grb2 SH2 domain-binding ligands","volume":"47","author":"Shi","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0092-8674(93)90405-F","article-title":"Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms","volume":"72","author":"Waksman","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2005.08.037_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/362087a0","article-title":"Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck","volume":"362","author":"Eck","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2005.08.037_bib19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0969-2126(00)00044-7","article-title":"Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase","volume":"2","author":"Lee","year":"1994","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2005.08.037_bib20","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1021\/jm970856n","article-title":"Potent antagonists of the SH2 domain of Grb2: optimization of the X+1 position of 3-amino-Z-Tyr(PO3H2)-X+1-Asn-NH2","volume":"41","author":"Garcia-Echeverria","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib21","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1021\/jm980159a","article-title":"Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain","volume":"41","author":"Furet","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1021\/jm0203635","article-title":"Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems","volume":"46","author":"Wei","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/jm9904248","article-title":"Inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands 2. 4-(2-malonyl)phenylalanine as a potent phosphotyrosyl mimetic","volume":"43","author":"Gao","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib24","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.1073\/pnas.97.17.9373","article-title":"Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity","volume":"97","author":"Shakespeare","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2005.08.037_bib25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/bip.10600","article-title":"Structure-based design of novel nonpeptide inhibitors of the Src SH2 domain:phosphotyrosine mimetics exploiting multifunctional group replacement chemistry","volume":"71","author":"Sundaramoorthi","year":"2003","journal-title":"Biopolymers"},{"key":"10.1016\/j.jmb.2005.08.037_bib26","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/jm0002681","article-title":"X-ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor","volume":"44","author":"Bohacek","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib27","doi-asserted-by":"crossref","first-page":"20238","DOI":"10.1074\/jbc.273.32.20238","article-title":"Carboxymethyl-phenylalanine as a replacement for phosphotyrosine in SH2 domain binding","volume":"273","author":"Tong","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib28","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/jm0110800","article-title":"Principles governing the binding of a class of non-peptidic inhibitors to the SH2 domain of src studied by X-ray analysis","volume":"45","author":"Lange","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib29","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/jm991013u","article-title":"Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic","volume":"42","author":"Furet","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1021\/jm9811007","article-title":"Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1)","volume":"42","author":"Ettmayer","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib31","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1021\/jm020970s","article-title":"Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors","volume":"46","author":"Lange","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib32","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1021\/jm030440b","article-title":"Synthesis of a 5-methylindolyl-containing macrocycle that displays ultrapotent Grb2 SH2 domain-binding affinity","volume":"47","author":"Shi","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2005.08.037_bib33","series-title":"Experiments in Molecular Genetics","author":"Miller","year":"1972"},{"key":"10.1016\/j.jmb.2005.08.037_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray Diffraction Data Collected in Oscillation Mode","volume":"276A","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jmb.2005.08.037_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0022-2836(68)90205-2","article-title":"Solvent content of protein crystals","volume":"33","author":"Matthews","year":"1968","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2005.08.037_bib36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1107\/S0907444904001982","article-title":"On the potential of normal-mode analysis for solving difficult molecular-replacement problems","volume":"60","author":"Suhre","year":"2004","journal-title":"Acta Crystallog. sect. D"},{"key":"10.1016\/j.jmb.2005.08.037_bib37","doi-asserted-by":"crossref","unstructured":"Collaborative Computing Project, Number 4 (1994). The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D, 50, 760-763.","DOI":"10.1107\/S0907444994003112"},{"key":"10.1016\/j.jmb.2005.08.037_bib38","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1107\/S0907444903028956","article-title":"Likelihood-enhanced fast rotation functions","volume":"60","author":"Storoni","year":"2004","journal-title":"Acta Crystallog. sect. D"},{"key":"10.1016\/j.jmb.2005.08.037_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1107\/S0108767390010224","article-title":"Improved methods for building protein models in electron density maps and the location of errors in these models","volume":"47","author":"Jones","year":"1991","journal-title":"Acta Crystallog. sect. A"},{"key":"10.1016\/j.jmb.2005.08.037_bib40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallog. sect. D"},{"key":"10.1016\/j.jmb.2005.08.037_bib41","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2002"},{"key":"10.1016\/j.jmb.2005.08.037_bib42","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1107\/S0021889891004399","article-title":"MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures","volume":"24","author":"Kraulis","year":"1991","journal-title":"J. Appl. Crystallog."},{"key":"10.1016\/j.jmb.2005.08.037_bib43","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1107\/S0907444994006396","article-title":"Raster3D version 2.0. A program for photorealistic molecular graphics","volume":"50","author":"Merritt","year":"1994","journal-title":"Acta Crystallog. sect. D"},{"key":"10.1016\/j.jmb.2005.08.037_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucl. Acids Res."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283605009745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283605009745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T11:23:05Z","timestamp":1548156185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283605009745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0022283605009745"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2005.08.037","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}